期刊文献+

HPLC法测定3个厂家生产的硫酸氢氯吡格雷片中有效成分及有关物质 被引量:3

HPLC in determination of effective contents and related substances in clopidogrel hydrogen sulfate produced by 3 manufacturers
下载PDF
导出
摘要 目的建立高效液相色谱法测定硫酸氢氯吡格雷片中有效成分S型氯吡格雷及有关物质R型氯吡格雷含量的方法,并比较3个厂家生产的氯吡格雷片中2种成分含量的差异。方法色谱条件:ULTRONES-OVM手性色谱柱(4.6mm×150mm,5μm),乙腈-0.01mol/L磷酸二氢钾溶液(20:80)为流动相,流速为1mL/min,柱温17℃,检测波长220nm。结果硫酸氢氯吡格雷S型及R型分别在50~117mg/L和1.52~30.4mg/L范围内线性关系良好(相关系数r均为0.9998),精密度良好,平均回收率分别为99.7%和98.8%,供试品溶液室温放置12h稳定;3个厂家生产的硫酸氢氯吡格雷片S型及R型的含量均符合药典要求。结论本方法准确度好,专属性强,可用于硫酸氢氯吡格雷片的质量控制。 Objective To establish a high performance liquid chromatography (HPLC) method for quantitative determination of S-clopidogrel and its related substance R-clopidogrel in clopidogrel tablets, and to compare their contents between clopidogrel tablets produced by three different manufacturers. Methods An ULTRON ES-OVM column ( 4.6 mm × 150 mm,5 μm) was used in this study. The mobile phase consisted of a mixture of acetonitrile and 0. 01 mol/L potassium dihydrogen phosphate solution (20 : 80). The flow-rate was 1 mL/min, with the column temperature being 17℃ and the UV detection wave lenth being 220 nm. Results S-clopidogrel and its related substance R-clopidogrel were in good linear relationship within 50-117 mg/L and 1. 52-30. 04 mg/L, respectively (both r= 0. 999 8). The precision of our method was satisfactory and the average recoveries were 99. 7% and 98. 8%, respectively. The test solution remained stable for 12 h. S-clopidogrel and R-clopidogrel in clopidogrel tablets produced by three manufacturers were in line with the quality requirements of pharmacopoeia. Conclusion Our method is accurate and has good specificity. It can be used for the quality control of clopidogrel tablets.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2014年第8期924-927,共4页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(81272819 81172514 81101658)~~
关键词 高压液相色谱法 硫酸氢氯吡格雷 有关物质 含量测定 high pressure liquid chromatography clopidogrel hydrogen sulfate related substances determination of content
  • 相关文献

参考文献11

  • 1Lynch D R Jr, Dantzler D M Jr, Zhao D. Prasugrel versus clopidogrel for acute coronary syndromes[J]. N Engl J Med, 2013, 368: 188.
  • 2Bhatt D L, Cryer B L, Contant C F, Cohen M, Lanas A, Schnitze T J, et al. Clopidogrel with or without omeprazole in coronary artery disease[J]. N Engl J Med, 2010, 363: 1909-1917.
  • 3Liu Y G, Gu X H. Pharmacology of chiral drugs[M]//Lin G Q, You Q D, Cheng J F. Chiral drugs: chemistry and biological action. Hoboken, New Jersey: John Wiley & Sons, 2011: 323-345.
  • 4Mohan A, Hariharan M, Vikraman E, Subbaiah G, Venkataraman B R, Saravanan D. Identification and characterization of a principal oxidation impurity in clopidogrel drug substance and drug product[J]. J Pharm Biomed Anal, 2008, 47: 183-189.
  • 5Gurav S, Venkatamahesh R. Development and validation of derivative UV-spectropotometric methods for quantitative estimation of clopidogrel in bulk and pharmaceutical dosage form[J]. Int J of Chem Tech Res, 2012, 4: 497-501.
  • 6吕洁,孟祥军,王凤秋.高效液相色谱法测定硫酸氢氯吡格雷的含量[J].中国医药导报,2011,8(9):60-61. 被引量:4
  • 7Sinha P K, DamLe M C, Bothara K G. A Validated stability indicating HPTLC method for determination of aspirin and clopidogrel bisulphate in combined dosage form[J]. Eurasian J Anal Chem, 2009, 4: 152-160.
  • 8Gomez Y, Adams E, Hoogmartens J. Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand[J]. J Pharm Biomed Anal, 2004, 34: 341-348.
  • 9Durga Rao D, Kalyanaraman L, Sait S S, Venkata Rao P. A validated stability-indicating normal phase LC method for clopidogrel bisulfate and its impurities in bulk drug and pharmaceutical dosage form[J]. J Pharm Biomed Anal, 2010, 52: 160-165.
  • 10Raijada D K, Prasad B, Paudel A, Shah R P, Singh S. Characterization of degradation products of amorphous and polymorphic forms of clopidogrel bisulphate under solid state stress conditions[J]. J Pharm Biomed Anal, 2010, 52: 332-344.

二级参考文献6

  • 1孙立平,张林潮.氯吡格雷在冠心病中的应用[J].医学综述,2006,12(19):1190-1192. 被引量:5
  • 2Mitakos, Panderi, Validated LC method for the determination of clopidogrel in pharmaceutical preparations [J].Journal of Pharmaceutical and Biochemical Analysis,2002,28(3):431-438.
  • 3国家药典委员会.新药转正标准:硫酸氢氯吡格雷[s].WSI-(X-471)-2003Z.
  • 4美国药典委员会.美国药典[M].30版.北京:中国知识出版社,2005.
  • 5Gandhimathi M, Ravi TK. High Performance liquid Chromatographic determination of aspirin and clopidgrel in tablets [J]. Indian J pharm Sci, 2007,69:123-125.
  • 6袁静.氯吡格雷的药理学、临床疗效和耐受性[J].中国临床药学杂志,1999,8(4):264-264. 被引量:8

共引文献3

同被引文献29

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部